Dual therapy versus triple therapy forHelicobacter pylori-associated duodenal ulcers Joseph J. Y. SungS. C. Sydney ChungArthur K. C. Li Esophageal, Gastric, And Duodenal Disorders Pages: 453 - 457
High seroprevalence ofHelicobacter pylori in diabetes mellitus patients B. OldenburgR. J. A. DieperslootJ. B. L. Hoekstra Esophageal, Gastric, And Duodenal Disorders Pages: 458 - 461
Gastric emptying andHelicobacter pylori infection in duodenal ulcer disease Francesco PerriYvo F. GhoosPaul J. Rutgeerts Esophageal, Gastric, And Duodenal Disorders Pages: 462 - 468
Omeprazole causes delay in gastric emptying of digestible meals Luigi BeniniGreta CastellaniItalo Vantini Esophageal, Gastric, And Duodenal Disorders Pages: 469 - 474
Bioavailability and efficacy of omeprazole given orally and by nasogastric tube Curtis LarsonNicholas J. CavutoRichard B. Weinberg Esophageal, Gastric, And Duodenal Disorders Pages: 475 - 479
Effects of cisapride on salivary production in normal subjects Rig PatelJan LaunspachEdy Soffer Esophageal, Gastric, And Duodenal Disorders Pages: 480 - 484
Pathways mediating pentagastrin-induced mucosal blood flow response in rat stomachs Shinichi KatoSusumu OkabeKoji Takeuchi Esophageal, Gastric, And Duodenal Disorders Pages: 485 - 491
High systemic HCO 3 − and topical 16,16-dimethyl-PGE2 protect gastric mucosa against luminal acid by enhancing its preepithelial buffer capacity T. Ranta-KnuuttilaH. MustonenE. Kivilaakso Esophageal, Gastric, And Duodenal Disorders Pages: 492 - 497
Stimulatory effects of sucralfate on secretion and synthesis of mucus by rabbit gastric mucosal cells Satoru TakahashiSusumu Okabe Esophageal, Gastric, And Duodenal Disorders Pages: 498 - 504
Esophageal dysphagia as the sole symptom in type I chiari malformation Grace H. EltaCary A. CaldwellTimothy T. Nostrant Case Report Pages: 512 - 515
Therapy with omeprazole and clarithromycin increases serum carbamazepine levels in patients withH. pylori gastritis H. -G. Dammann Letters To The Editor Pages: 519 - 519
Nonsteroidal antiinflammatory drug-induced colitis and misoprostol Xavier HebuterneGilles DreyfusPatrick Rampal Letters To The Editor Pages: 520 - 521
Increase of swallows before onset of phase III of migrating motor complex in normal human subjects Leonardo MarzioLaurino GrossiDomenico Lapenna Motility, Nerve-Gut Interactions, Hormones, And Receptors Pages: 522 - 527
Influence of blood glucose levels on rat liquid gastric emptying Full-Young ChangShou-Dong LeePaulus S. Wang Motility, Nerve-Gut Interactions, Hormones, And Receptors Pages: 528 - 532
Resting energy expenditure in patients with alcoholic chronic pancreatitis Xavier HébuternePatrick HastierPatrick Rampal Pancreatic And Biliary Disorders Pages: 533 - 539
Survey of cystic fibrosis transmembrane conductance regulator genotypes in primary sclerosing cholangitis James M. McGillDiane M. WilliamsChristine M. Hunt Pancreatic And Biliary Disorders Pages: 540 - 542
Effect of cisapride on gallbladder emptying and plasma CCK in normal and vagotomized human subjects R. PatankarM. M. OzmenC. D. Johnson Pancreatic And Biliary Disorders Pages: 543 - 548
Comparison of post-ERCP biological pancreatitis in chronic alcoholic and control nonalcoholic group P. HastierA. G. HarrisJ. P. Delmont Letters To The Editor Pages: 549 - 549
Chronic pancreatitis withα 1-Antitrypsin deficiency: From uncontrolled trypsin activation? Michael O. Blackstone Letters To The Editor Pages: 549 - 550
Response by Drs. Ertan, Schwartz, and Rabassa Atilla ErtanMary SchwartzAlfredo Rabassa Letters To The Editor Pages: 550 - 551
Small bowel bacterial overgrowth in patients with alcoholic cirrhosis F. Casafont MorencosG. de Las Heras CastañoF. Pons Romero Liver: Cirrhosis, Fibrosis, Portal Hypertension, And Transplantation Pages: 552 - 556
Gastrointestinal dysfunction in liver disease and portal hypertension Eamonn M. M. Quiqley Editorial Pages: 557 - 561
Differences in hemostasis among sclerosing agents in endoscopic injection sclerotherapy M. TatemichiH. NagataH. Ishii Liver: Cirrhosis, Fibrosis, Portal Hypertension, And Transplantation Pages: 562 - 570
Peritoneal fibrosis in cirrhotics treated with peritoneovenous shunting for ascites Malcolm M. StanleyCesar V. ReyesGeorge F. Reinhardt Liver: Cirrhosis, Fibrosis, Portal Hypertension, And Transplantation Pages: 571 - 577
Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt O. RiggioM. MerliL. Capocaccia Liver: Cirrhosis, Fibrosis, Portal Hypertension, And Transplantation Pages: 578 - 584
Gastric functions in portal hypertension Ömer GünalCumhur YeğenBerrak Ç. Yeğen Liver: Cirrhosis, Fibrosis, Portal Hypertension, And Transplantation Pages: 585 - 590
Lymphangioleiomyomatosis, chylous ascites, and diet Elpidio CalvoLuis AmarillasDomingo Espinos Case Report Pages: 591 - 593
Pyoderma gangrenosum with hepatopancreatic manifestations in a patient with rheumatoid arthritis P. HastierF. X. Caroli-BoscJ. P. Delmont Case Report Pages: 594 - 597
Incidence and outcome of overt gastrointestinal bleeding in patients undergoing bone marrow transplantation Suman KaurGregory CooperHillard M. Lazarus Gastrointestinal Oncology Pages: 598 - 603
Prolonged hypergastrinemia does not increase the frequency of colonic neoplasia in patients with Zollinger-Ellison syndrome Murray OrbuchDavid J. VenzonRobert T. Jensen Gastrointestinal Oncology Pages: 604 - 613
Increased substance P receptor expression by blood vessels and lymphoid aggregates inClostridium difficile-induced pseudomembranous colitis Christopher R. MantyhJohn E. MaggioTheodore N. Pappas Case Report Pages: 614 - 620
Enterocolitis in infantile common variable immunodeficiency Helen A. JohnKathleen E. SullivanAndrew E. Mulberg Case Report Pages: 621 - 623
Pleuropericarditis related to the use of mesalamine Navjyot GujralFrank FriedenbergGary Levine Case Report Pages: 624 - 626
An unusual presentation of intestinal duplication with a literature review Mark I. OtterChristopher G. MarksMartin G. Cook Case Report Pages: 627 - 629
